NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Range of suitable individuals: CDEC talked over the uncertainty in the quantity of sufferers with moderately significant to significant hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical gurus consulted by CADTH indicated that some patients who are categorised as owning delicate or reasonable condition can have a critical bleed